Clinical Trial: A Clinical Trial of MK-8644 in Healthy Participants and Participants With Psoriasis (MK-8644-001)

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07850310) titled 'A Clinical Trial of MK-8644 in Healthy Participants and Participants With Psoriasis (MK-8644-001)' on Sept. 24.

Brief Summary: The purpose of this trial is to learn about a trial medicine called MK-8644. This trial is the first time researchers will give MK-8644 to people.

This trial will help researchers learn about the safety of MK-8644 and if participants tolerate it. Tolerate means participants will receive MK-8644 in the trial unless they need to stop it due to health problems.

Study Start Date: Oct. 06

Study Type: INTERVENTIONAL

Condition: Psoriasis Healthy

Intervention: DRUG: MK-8644

Oral administration

DRUG: Placebo ...